Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unacylated Ghrelin in PAD (GIFT)
NCT03358355Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jun 2016
- Primary completion
- Aug 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of unacylated ghrelin in peripheral artery disease (PAD), sponsored by Northwestern University. Started Jun 2016; status: completed.
02
Drugs
unacylated ghrelin
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT03358355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03358355.